MESYNKRO
Live / Allowed — Approved for publication (as of 02 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99487710
- Mark type
- Stylized text
- Filed
- 10 Nov 2025
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
Prosecution history
- 02 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Feb 2026 — NON-FINAL ACTION E-MAILED
- 05 Feb 2026 — NON-FINAL ACTION WRITTEN
- 05 Feb 2026 — ASSIGNED TO EXAMINER
- 10 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Nov 2025 — NEW APPLICATION ENTERED